Hi-Clearance Inc. (TPEX:1788)
Taiwan · Delayed Price · Currency is TWD 136.50
-0.50 (-0.36%)
At close: Dec 5, 2025
Hi-Clearance Market Cap
Hi-Clearance has a market cap or net worth of 6.08 billion as of December 5, 2025. Its market cap has decreased by -1.44% in one year.
Market Cap
6.08B
Enterprise Value
6.77B
Revenue
4.19B
Ranking
n/a
PE Ratio
17.39
Stock Price
136.50
Market Cap Chart
Since October 18, 2004, Hi-Clearance's market cap has increased from 875.00M to 6.08B, an increase of 594.53%. That is a compound annual growth rate of 9.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 6.08B | -2.15% |
| Dec 31, 2024 | 6.21B | 2.95% |
| Dec 29, 2023 | 6.03B | 3.39% |
| Dec 30, 2022 | 5.84B | -0.35% |
| Dec 30, 2021 | 5.86B | 30.65% |
| Dec 31, 2020 | 4.48B | 18.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 258.22B |
| PharmaEssentia | 191.95B |
| Lotus Pharmaceutical | 78.89B |
| Bora Pharmaceuticals Co., LTD. | 65.31B |
| Lin BioScience | 33.46B |
| Oneness Biotech | 32.96B |
| Lumosa Therapeutics | 32.77B |
| Center Laboratories | 27.88B |